Advertisements



We are Sorry, This Page doesn't Exist


Cerecor doses first patient in Phase 1b proof-of-concept trial of CERC-007

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 5th, 2021

Repare Therapeutics doses first patient in Phase 1 clinical trial of RP-6306

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2021

Aravive doses first patient in Phase III AVB-500 trial, says Piper Sandler

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 27th, 2021

Synthetic Biologics doses first patient in Phase 1b/2a trial of aGVHD candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2021

Kadmon doses first patient in phase 2 clinical trial of Belumosudil

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2021

Altimmune reports data from phase 1B clinical trial of NasoShield

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2021

Dynavax doses first patient in Phase 2/3 trial for COVID-19 vaccine candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 24th, 2021

Galmed doses first patient in Phase I clinical trial evaluating Amilo-5MER

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 16th, 2021

4D Molecular doses first patient in Phase 1/2 trial of 4D-310

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 9th, 2021

Aravive doses first patient in Phase 1b/2 trial of AVB-500

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 8th, 2021

Marker Therapeutics doses first patient in Phase 2 trial of MT-401 in AML

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 3rd, 2021

Applied Molecular Transport doses patient in Phase 1a trial of AMT-126

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 1st, 2021

Inovio doses first patient in Phase 1B clinical trial for INO-4500

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Monopar Therapeutics doses first patient in Phase 2b/3 VOICE trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 16th, 2021

Atea doses first patient in Phase 2 trial of AT-527 in COVID-19 patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 4th, 2021

BridgeBio doses first patient in Phase 1/2 trial of BBP-681 for malformations

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 2nd, 2021

EyePoint doses first patient in Phase 1 clinical trial of EYP-1901

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytJan 28th, 2021

F-star Therapeutics doses first patient in FS222 Phase 1 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 4th, 2021

Ocular Therapeutix doses firs patient in OTX-CSI Phase 1 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2020

Rubius Therapeutics doses first patient in Phase 1/2 trial of RTX-240

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2020